Skip to main content
ALIVUS LIFE SCIENCES LIMITED logo

ALIVUS LIFE SCIENCES LIMITED — Investor Relations & Filings

Ticker · ALIVUS ISIN · INE03Q201024 LEI · 335800RYVA1DKP696G32 BSE.NS Manufacturing
Open in API
Filings indexed 352 across all filing types
Latest filing 2025-05-23 Call Transcript
Country IN India
Listing BSE.NS ALIVUS

About ALIVUS LIFE SCIENCES LIMITED

https://www.alivus.com

Alivus Life Sciences Limited is a pharmaceutical organization dedicated to the formulation, production, and commercialization of a broad spectrum of healthcare solutions. The company operates across multiple therapeutic categories, including gastroenterology, anti-infectives, pain management, and nutritional supplements. Its product range includes diverse delivery formats such as tablets, capsules, syrups, and injectable medications. Alivus Life Sciences focuses on maintaining rigorous quality control protocols and manufacturing excellence to deliver reliable therapeutic outcomes. The company utilizes a robust distribution infrastructure to supply its pharmaceutical products to healthcare providers and patients, prioritizing the accessibility of essential medicines and the continuous expansion of its therapeutic portfolio.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings call held on May 16, 2025, discussing the financial results for the quarter and year ended March 31, 2025. It includes management commentary on company performance, financial metrics such as revenue, EBITDA, PAT, CAPEX plans, and Q&A with analysts. The text explicitly mentions it is a transcript of the earnings call and contains detailed financial data and management discussion. Therefore, this document fits the category of a Call Transcript (CT).
2025-05-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) disclosing an upcoming investor/analyst meeting as per Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It provides details of the meeting date, mode, place, and type. The document is short (1985 characters) and serves as an intimation or announcement rather than a detailed report or transcript. There is no financial data, no discussion of financial results, no voting results, no management changes, or other report content. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about an investor meeting under SEBI regulations.
2025-05-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the uploading of the audio recording of the Q4 & FY2024-25 Earnings Call. It references SEBI regulations and provides a link to the audio recording. The document does not contain the transcript or financial data itself, but rather confirms the availability of the earnings call recording. The document length is short (1651 characters), and it is essentially an announcement to take the recording on record. According to the rules, this is not the earnings release or call transcript itself, but an announcement related to the earnings call. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other categories more specifically.
2025-05-16 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation – Q4 & FY 24-25' and is addressed to stock exchanges referencing scrip codes and names, indicating a formal disclosure. It contains detailed financial performance data for Q4 and full fiscal year 2025, including revenue, EBITDA, PAT, segmental performance, market mix, and company overview. The text includes forward-looking statements and disclaimers typical of investor presentations. The document length is about 15,000 characters, which is consistent with a detailed presentation rather than a brief announcement. There is no indication that this is a full annual report (10-K) or interim report (IR), nor is it a regulatory filing or certification. The content focuses on financial highlights, business performance, and strategic outlook, which aligns with the definition of an Investor Presentation (IP). Therefore, the document should be classified as an Investor Presentation (IP).
2025-05-15 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the financial results for the fourth quarter and full fiscal year ended March 31, 2025. It includes detailed financial performance metrics such as revenue, EBITDA, PAT, margins, cash flow, and management commentary. The document is addressed to stock exchanges and references regulatory compliance under SEBI listing obligations. It is not a full annual report but an initial announcement of quarterly and annual financial results. The length (6805 characters) and content indicate it is more than a brief summary but does not contain full financial statements or comprehensive analysis typical of an Annual Report (10-K) or Interim Report (IR). The document fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results with key highlights and management commentary. FY 2025
2025-05-15 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a formal announcement addressed to stock exchanges regarding the appointment of a Secretarial Auditor, pursuant to Regulation 30 of the SEBI Listing Regulations. It details the appointment, term, and profile of the auditor but does not contain any financial data, audit results, or detailed reports. The document is relatively short (4454 characters) and serves as a regulatory disclosure about a management-related appointment rather than a full management report or audit report. This fits best under the category of Board/Management Information (MANG), which covers announcements of changes in company management or board appointments.
2025-05-15 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.